Drug Shortage Report for DANTRIUM INTRAVENOUS

Last updated on 2025-11-08 History
Report ID 269411
Drug Identification Number 01997572
Brand name DANTRIUM INTRAVENOUS
Common or Proper name DANTROLENE SODIUM
Company Name ENDO OPERATIONS LTD.
Market Status MARKETED
Active Ingredient(s) DANTROLENE SODIUM
Strength(s) 20MG
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 6x 20mg vials
ATC code M03CA
ATC description MUSCLE RELAXANTS, DIRECTLY ACTING AGENTS
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2025-10-10
Estimated end date 2025-11-10
Actual end date 2025-11-07
Shortage status Resolved
Updated date 2025-11-08
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 1ST FLOOR, MINERVA HOUSE, SIMMONSCOURT ROAD
BALLSBRIDGE, DUBLIN
IRELAND D04 H9P8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v11 2025-11-08 English Compare
v10 2025-11-07 French Compare
v9 2025-11-07 English Compare
v8 2025-11-07 French Compare
v7 2025-11-07 English Compare
v6 2025-10-30 French Compare
v5 2025-10-30 English Compare
v4 2025-10-20 French Compare
v3 2025-10-20 English Compare
v2 2025-10-14 French Compare
v1 2025-10-14 English Compare

Showing 1 to 11 of 11